Ixchelsis successfully closes series A funding with TVM Life Science Ventures VII and concludes asset transfer agreement with Pfizer Inc

Montreal, August 6, 2013 – Ixchelsis Ltd and TVM Life Science Ventures VII today announced the fund’s second investment – Ixchelsis Ltd, a start-up company based at Discovery Park, Sandwich, Kent, UK. Ixchelsis plans to develop to proof-of-concept, IX-01, an investigational compound, originally discovered at Pfizer’s, Sandwich, UK, R&D site, with the potential to treat the male sexual health indication, premature ejaculation…  Read More >>